Phase IIa Clinical Trial of Trans-1-Amino-3-18F-Fluoro-Cyclobutane Carboxylic Acid in Metastatic Prostate Cancer

机译：Trans-1-Amino-3-18F-氟-环丁烷羧酸在转移性前列腺癌中的IIa期临床试验

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

Objective(s):We performed a phase IIa clinical trial of trans-1-amino-3-¹⁸F-fluoro-cyclobutane carboxylic acid (anti-¹⁸F-FACBC), a synthetic amino acid analog for PET, in patients with metastatic prostate cancer.

机译：目的：我们进行了反-1-氨基-3- ^{18 F-氟代环丁烷羧酸（anti- ^{18 F-FACBC）的IIa期临床试验），一种用于转移性前列腺癌患者的PET合成氨基酸类似物。}}

著录项

期刊名称 Asia Oceania Journal of Nuclear Medicine and Biology
作者
Yusuke Inoue; Yuji Asano; Takefumi Satoh; Ken-ichi Tabata; Kei Kikuchi; Reiko Woodhams; Shiro Baba; Kazushige Hayakawa;
展开▼
作者单位

展开▼
年(卷),期 2014(2),2
年度 2014
页码 87–94
总页数 8
原文格式 PDF
正文语种
中图分类放射医学;影像诊断学;
关键词
Anti-sup18/supF-FACBC Metastasis Positron Emission Tomography Prostate cancer;

机译：抗sup 18 / sup F-FACBC;转移;正电子发射断层扫描;前列腺癌;

相似文献

外文文献
中文文献
专利

1. Phase IIa Clinical Trial of Trans-1-Amino-3-18F-Fluoro- Cyclobutane Carboxylic Acid in Metastatic Prostate Cancer [J] . Yusuke Inoue, Yuji Asano, Takefumi Satoh, Asia Oceania Journal of Nuclear Medicine & Biology . 2014,第2期

机译：反式-1-氨基-3-18F-氟-环丁烷羧酸在转移性前列腺癌中的IIa期临床试验
2. Phase I/IIa clinical trial of a novel hTERT peptide vaccine in men with metastatic hormone-naive prostate cancer [J] . Lilleby Wolfgang, Gaudernack Gustav, Brunsvig Paal F., Cancer immunology, immunotherapy : . 2017,第7期

机译：I / IIa在具有转移激素 - 野前列腺癌的男性中新型HTERT肽疫苗的临床试验
3. Re: Liselotte MS Boeve, Maarten CCM Hulshof, Andre N. Vis, et al. Effect on Survival of Androgen Deprivation Therapy Alone Compared to Androgen Deprivation Therapy Combined with Concurrent Radiation Therapy to the Prostate in Patients with Primary Bone Metastatic Prostate Cancer in a Prospective Randomised Clinical Trial: Data from the HORRAD Trial. Eur Urol 2019; 75: 410-8 Future Steps for Definitive Therapy in Metastatic Prostate Cancer: Lessons from the HORRAD Trial [J] . Shinde Ashwin, Li Richard, Amini Arya, European urology . 2019,第3期

机译：Re：Liselotte Ms Boeve，Maarten CCM Hulshof，Andre N. Vis等人。与雄激素剥夺治疗相比，对雄激素剥夺治疗的生存对雄激素剥夺治疗与前瞻性随机临床试验中原发性骨转移前列腺癌前列腺患者的同时剥夺治疗的影响：来自血腥审判的数据。 EUR UROL 2019; 75：410-8转移性前列腺癌中的明确治疗的未来步骤：来自血轮试验的教训
4. Effects of laser immunotherapy on late-stage, metastatic breast cancer patients in a Phase Ⅱ clinical trial [C] . Gabriela L. Ferrel, Feifan Zhou, Xiaosong Li, Biophotonics and immune responses IX . 2014

机译：Ⅱ期临床试验中激光免疫疗法对晚期转移性乳腺癌患者的影响
5. Clinical predictive value of pre-clinical cancer models: A study of the predictive value of the in vitro cell line, human xenograft and murine allograft pre-clinical cancer models for phase II clinical trials of cytotoxic cancer drugs [D] . Voskoglou-Nomikos, Theodora 2001

机译：临床前癌症模型的临床预测价值：体外细胞系，人异种移植和小鼠同种异体移植临床前癌症模型对细胞毒性癌症药物II期临床试验的预测价值研究
6. A phase II trial of ganetespib a heat shock protein 90 Hsp90) inhibitor in patients with docetaxel-pretreated metastatic castrate-resistant prostate cancer (CRPC)-a prostate cancer clinical trials consortium (PCCTC) study [O] . Manish K. Thakur, Lance K. Heilbrun, Shijie Sheng, -1

机译：ganetespib（一种热休克蛋白90 Hsp90）抑制剂的II期临床试验在多西他赛预处理的转移性去势抵抗性前列腺癌（CRPC）患者中进行-前列腺癌临床试验联盟（PCCTC）研究
7. Erratum to: Cilengitide (EMD 121974, NSC 707544) in asymptomatic metastatic castration resistant prostate cancer patients: a randomized phase II trial by the prostate cancer clinical trials consortium [O] . Deborah A. Bradley, Stephanie Daignault, Charles J. Ryan, 2010

机译：错误至：西生苷（EMD 121974，NSC 707544）在无症状转移性阉割前列腺癌患者中：前列腺癌临床试验联盟的随机期II试验

Phase IIa Clinical Trial of Trans-1-Amino-3-18F-Fluoro-Cyclobutane Carboxylic Acid in Metastatic Prostate Cancer

摘要

著录项

相似文献

相关主题

期刊订阅